iShares China Large-Cap ETF vs Medline Inc. Class A Common Stock — how do they compare? iShares China Large-Cap ETF trades at $33.93 (market cap $3.90B), while Medline Inc. Class A Common Stock trades at $35.74 (market cap $31.10B). The key difference: Medline Inc. Class A Common Stock is far larger — about 8× iShares China Large-Cap ETF's market cap, and iShares China Large-Cap ETF is more actively traded (16,526,479 versus 4,471,639). Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 149 Days and Medline Inc. Class A Common Stock for 0 Days on average.
| FXI | MDLN | |
|---|---|---|
Market Cap | $3.90B | $31.10B |
Volume | 16,526,479 | 4,471,639 |
52-Week High | $41.08 | $49.99 |
52-Week Low | $31.59 | $31.64 |
Typical Hold Time | 149 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $41.07B |
Signals from Pluang's Aura AI — not financial advice
FXI (iShares China Large-Cap ETF) trades at $33.42, down 1.04% with a bearish technical outlook. The ETF shows compelling valuation at half the S&P 500's P/E ratio with a 1.98% yield, but faces headwinds from China's economic challenges and geopolitical tensions. Recent corporate profit growth of 26% in Q2 2026 provides fundamental support, though weak momentum persists amid global trade concerns.
The ETF offers diversification value and valuation appeal but carries significant political and economic risks. China's industrial overcapacity and weak domestic consumption create volatility, while U.S.-China relations remain a key variable. Institutional interest focuses on long-term value despite near-term bearish technical signals.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →